Subsequent Events

6 Months Ended

Jun. 30, 2013

Subsequent Events [Abstract]

Subsequent Events

Note 6. Subsequent Events

    The INSERM contract is under negotiation and will likely be finalized in September 2013.

    On August 5, 2013, Round Enterprises Ltd and Eardley Holding AG each provided a convertible loan of E320 and E80, respectively, with a 10% interest per annum and a maturity date of September 30, 2013. This maturity date is automatically prolonged for periods of three months, unless called for repayment. The conversion price is determined by the lower of (i) reducing by 10% the price per share of the Company’s common stock paid by the investors in connection with an investment in the Company of not less than $20,000 or (ii) at US$ 0.0177 per share of the Company’s common stock, and using a fixed exchange rate of $1.3283 per Euro.

    To address the possibility where all shareholder loans, options, warrants or other potentially dilutive securities are converted into shares and thereby creating a situation that the potential issuable shares of Mymetics common stock exceeds the authorized shares, the Board of Directors approved the increase in the authorized common shares of Mymetics from 495 million to 850 million and recommended this amendment to the Company’s Certificate of Incorporation to the Company’s shareholders.  The Company has received consent of a majority of its shareholders to amend the Company’s charter to increase its authorized shares and intends to notify the shareholders of the increase in authorized shares through a Schedule 14C filing.